Landsteiner Scientific, S.A. de C.V., a pharmaceutical company, engages in the research, development, manufacture, distribution, and marketing of healthcare products primarily in Mexico, the United States, and Europe. The company offers products in various therapeutic areas, including cardiology, endocrología, gynecology, nephrology, neurology, oncology, transplant, and urology. It also provides pain and inflammation products, including analgesic-anti-inflammatory and neuropathic pain products; anti-infective products, such as antibiotics, antifungal, and antiviral products; central nervous system products comprising antiemetic, depression, epilepsy, and haemorrheologic products; and metabol...
Av. Periférico Sur No. 4118
Col. Jardines De Pedregal
Mexico City, DF 01900
Founded in 1998
Iroko Pharmaceuticals Inc. Signs New Strategic Agreement with Landsteiner Scientific, S.A. de C.V to Bring ZORVOLEX(R) to Mexico
Oct 21 14
Iroko Pharmaceuticals Inc. signed a licensing agreement with Landsteiner Scientific, S.A. de C.V., for the exclusive rights to market and sell ZORVOLEX(R) (diclofenac) capsules in Mexico. Landsteiner Scientific will be responsible for obtaining regulatory and pricing approval, as well as the marketing and distribution of the medication. ZORVOLEX is approved by the United States Food and Drug Administration (FDA) for the management of mild to moderate acute pain and osteoarthritis pain. ZORVOLEX is not currently approved for marketing in any other country. Iroko will continue to retain all marketing rights to ZORVOLEX in the U.S.
Landsteiner Scientific, S.A. de C.V Presents at BioPharma Mexico 2013, Oct-30-2013 03:35 PM
Oct 8 13
Landsteiner Scientific, S.A. de C.V Presents at BioPharma Mexico 2013, Oct-30-2013 03:35 PM. Venue: Hyatt Regency Mexico City, Mexico. Speakers: Francisco Kuri Breña, Director of New Development.